UUUIPS Profile Banner
Utrecht Institute for Pharmaceutical Sciences Profile
Utrecht Institute for Pharmaceutical Sciences

@UUUIPS

Followers
138
Following
46
Media
3
Statuses
79

Utrecht Institute for Pharmaceutical Sciences; Faculty of Science; Utrecht University; the Netherlands.

Utrecht, The Netherlands
Joined January 2022
Don't wanna be here? Send us removal request.
@JCRnEDITORS
J Controlled Release
7 months
Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models/ | Massimiliano Caiazzo @UUUIPS | @CRSBeNeLuxFr [Open Access] #nanobody #transcytosis #BloodBrainBarrier https://t.co/InO7OWLnf3
0
1
5
@RobertPdeVries1
Robert P. de Vries
11 months
Save the date! June 27th is our 3rd GlycoScienceNL symposium...Geertekerk Utrecht! major #glycotime! @UU_Glycoscience @UUUIPS https://t.co/DTkPWgOmQ4 Please tag and RT at will!
0
4
3
@ACSBioMed
ACS Publications Bio & Med Chem Content
1 year
New Editors' Choice article in #ACSInfectiousDiseases 🏅 📑 The HCoV-HKU1 N-Terminal Domain Binds a Wide Range of 9-O-Acetylated Sialic Acids Presented on Different Glycan Cores 🖊 Ilhan Tomris et al @UUUIPS Read for free ➡ https://t.co/WYgdlIHaBY
0
1
4
@RobertPdeVries1
Robert P. de Vries
1 year
Another week another editors’ pick, now out in ACS Infectious Diseases. HKU is quite promiscuous for glycan cores snd only really cares for 9-0-acetylated sialic acids
Tweet card summary image
pubs.acs.org
Coronaviruses (CoVs) recognize a wide array of protein and glycan receptors by using the S1 subunit of the spike (S) glycoprotein. The S1 subunit contains two functional domains: the N-terminal...
1
16
29
@RicLevato
rlevato
2 years
Last Friday @mfalandt joined @UniStemDay @UniUtrecht to share our lab's work @ERC_Research #Volumebio and his research experience! So nice to see all the curiosity and interest from the high school students present #STEMeducation #Unistemday2024 thanks @UUUIPS for organizing
0
5
10
@UUPharmaceutics
Pharmaceutics Utrecht
2 years
The 2024 Advanced Functional Polymers for Medicine Conference will take place at @UUUIPS, June 5-7! Discover the latest developments in polymer-based systems for drug delivery, regenerative medicine & diagnostics. Info & registration (limited spots!): https://t.co/6P4yVDIW4e
0
1
1
@UUBeta
Faculty of Science, Utrecht University
2 years
Many new cancer drugs in the EU lack clear proof of added benefit. But still nearly all those drugs manage to recover their substantial research and development (R&D) costs relatively quickly after approval. @UUUIPS #healthcare #costs https://t.co/Ku1NRed66w
Tweet card summary image
uu.nl
Many cancer drugs recently approved by the European Medicines Agency (EMA) lack clear proof of added benefit. This is particularly the case for drugs that are granted via special processes, intended...
0
1
1
@UUUIPS
Utrecht Institute for Pharmaceutical Sciences
2 years
Very relevant articles: Many new oncology drugs approved in the EU lack proof of added benefit
Tweet card summary image
uu.nl
Many cancer drugs recently approved by the European Medicines Agency (EMA) lack clear proof of added benefit. This is particularly the case for drugs that are granted via special processes, intended...
0
0
2
@RobertPdeVries1
Robert P. de Vries
2 years
Assymetry for the win! 10+ years of N-glycan synthesis and here we demonstrate that human influenza A viruses preferentially bind to the the a3 arm! #glycotime https://t.co/dsq298xIlD
pubs.acs.org
Glycan binding properties of respiratory viruses have been difficult to probe due to a lack of biologically relevant glycans for binding studies. Here, a stop-and-go chemoenzymatic methodology is...
4
17
49
@kestecker
Kelly E. Stecker
2 years
Interested in the fascinating field of microproteins? Join my group in a collaboration with @s_heesch at the PMC. PostDocs apply below: https://t.co/G52z1I7HR0 @hecklab @prinsesmaximac
0
16
16
@UU_Glycoscience
CBDD (Chemical Biology & Drug Discovery)
2 years
Analytical #glycotime! If you are interested in analyzing O-acetylated sialoside-containing glycoproteins with precision, differentiating all O-Ac positional isomers, take a look at this one from @TheBoonsGroup. https://t.co/iOjt9tAbqC @UUUIPS @UUBeta
Tweet card summary image
nature.com
Nature Communications - O-acetylation is a common modification of sialic acids. Here, a library of synthetic O-acetylated sialosides made it possible to develop an ion mobility mass spectrometry...
1
2
5
@UU_Glycoscience
CBDD (Chemical Biology & Drug Discovery)
2 years
@mehmanbunyadov of @TheBoonsGroup developed a strategy for making HNK glycans. Backbone were prepared using enzymes, then chemical modifications. This is a reversal from what’s normally done in chemoenzymatic glycan assembly. You wanna coin a new term, Mehman? @UUUIPS @UUBeta
@NatureSynthesis
Nature Synthesis
2 years
Now online: Article by @mehmanbunyadov, Geert-Jan Boons & co-workers @TheBoonsGroup @UU_Glycoscience Chemoenzymatic synthesis of human natural killer-1-containing glycans and application as serum antibodies probes https://t.co/CU6PdVrUGp ($)
0
3
11
@UUUIPS
Utrecht Institute for Pharmaceutical Sciences
2 years
Congratulations to new UIPS PI's Kelly Stecker and @BvRavensteijn for receiving prestigious grants https://t.co/3JYPNubCSj @UUPharmaceutics @hecklab
Tweet card summary image
uu.nl
Two new PI's of UIPS have recently been successful in obtaining prestigious grants
0
1
4
@UUUIPS
Utrecht Institute for Pharmaceutical Sciences
2 years
0
0
1
@UUUIPS
Utrecht Institute for Pharmaceutical Sciences
2 years
Success for chemical biology researchers. Two PIs from UIPS have received NWO Impulse funding.
Tweet card summary image
uu.nl
Just before the summer a VENI and a VIDI grant landed in the same group.
1
2
7
@StrategyCKD
strategy.ckd
2 years
https://t.co/JU1A5t2MMf An excellent systematic review on ‘Animal Models for Studying Protein-Bound Uremic Toxin Removal’! In which Prof Masereeuw and @SilviaMMihaila from our consortium partners @UUUIPS were involved in 🔬#ckd #strategyckd #kidney
Tweet card summary image
mdpi.com
Protein-bound uremic toxins (PBUTs) are associated with the progression of chronic kidney disease (CKD) and its associated morbidity and mortality. The conventional dialysis techniques are unable to...
0
3
7